Kindstar Globalgene Technology, Inc. (SEHK:9960) entered into a equity transfer agreement to acquire 11.38% stake in Beijing Bofurui Gene Diagnostic Technology Co., Ltd. for CNY 31.9 million on June 30, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.41 HKD | -0.70% |
|
+1.44% | -16.07% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.07% | 17Cr | |
-18.17% | 854.72Cr | |
+80.30% | 463.15Cr | |
+16.31% | 298.41Cr | |
-3.15% | 265.3Cr | |
-8.34% | 189.4Cr | |
-54.77% | 181.31Cr | |
-13.25% | 156.12Cr | |
+23.57% | 127.13Cr | |
-47.38% | 106.99Cr |
- Stock Market
- Equities
- 9960 Stock
- News Kindstar Globalgene Technology, Inc.
- Kindstar Globalgene Technology, Inc. entered into a equity transfer agreement to acquire 11.38% stake in Beijing Bofurui Gene Diagnostic Technology Co., Ltd. for CNY 31.9 million.